Henry Schein Q3 EPS Estimate Decreased by Leerink Partnrs

Henry Schein, Inc. (NASDAQ:HSIC) – Analysts at Leerink Partnrs dropped their Q3 2025 earnings estimates for Henry Schein in a report issued on Monday, July 14th. Leerink Partnrs analyst M. Cherny now expects that the company will earn $1.25 per share for the quarter, down from their prior forecast of $1.30. The consensus estimate for Henry Schein’s current full-year earnings is $4.74 per share.

Henry Schein (NASDAQ:HSIC) last announced its earnings results on Monday, May 5th. The company reported $1.15 EPS for the quarter, beating analysts’ consensus estimates of $1.11 by $0.04. Henry Schein had a net margin of 3.21% and a return on equity of 14.87%. The business had revenue of $3.17 billion during the quarter, compared to analysts’ expectations of $3.24 billion. During the same period in the prior year, the company earned $1.10 earnings per share. The firm’s revenue was down .1% on a year-over-year basis.

A number of other analysts have also recently commented on the stock. Baird R W cut shares of Henry Schein from a “strong-buy” rating to a “hold” rating in a report on Monday. Piper Sandler reduced their price objective on shares of Henry Schein from $83.00 to $77.00 and set an “overweight” rating for the company in a research note on Wednesday, April 30th. Robert W. Baird reissued a “neutral” rating and issued a $72.00 price objective (down from $82.00) on shares of Henry Schein in a research note on Monday. Leerink Partners set a $75.00 price objective on shares of Henry Schein in a research note on Monday. Finally, Wells Fargo & Company reduced their price objective on shares of Henry Schein from $80.00 to $75.00 and set an “equal weight” rating for the company in a research note on Tuesday, May 6th. Eight research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $78.36.

Henry Schein Stock Up 0.3%

Shares of HSIC stock opened at $69.50 on Thursday. Henry Schein has a 12 month low of $60.56 and a 12 month high of $82.49. The stock has a market cap of $8.46 billion, a P/E ratio of 21.72, a P/E/G ratio of 2.24 and a beta of 0.87. The company has a current ratio of 1.38, a quick ratio of 0.75 and a debt-to-equity ratio of 0.50. The company has a 50 day simple moving average of $71.80 and a two-hundred day simple moving average of $71.32.

Institutional Trading of Henry Schein

Institutional investors and hedge funds have recently bought and sold shares of the stock. Farther Finance Advisors LLC increased its holdings in Henry Schein by 237.3% in the 1st quarter. Farther Finance Advisors LLC now owns 2,698 shares of the company’s stock valued at $186,000 after acquiring an additional 1,898 shares during the last quarter. State of Alaska Department of Revenue increased its holdings in Henry Schein by 2.8% in the 1st quarter. State of Alaska Department of Revenue now owns 14,611 shares of the company’s stock valued at $1,000,000 after acquiring an additional 395 shares during the last quarter. Oppenheimer Asset Management Inc. increased its holdings in Henry Schein by 5.2% in the 1st quarter. Oppenheimer Asset Management Inc. now owns 13,745 shares of the company’s stock valued at $941,000 after acquiring an additional 678 shares during the last quarter. GAMMA Investing LLC lifted its position in Henry Schein by 37.8% during the first quarter. GAMMA Investing LLC now owns 3,939 shares of the company’s stock valued at $270,000 after purchasing an additional 1,081 shares during the last quarter. Finally, Wellington Management Group LLP lifted its position in Henry Schein by 12.6% during the fourth quarter. Wellington Management Group LLP now owns 6,902 shares of the company’s stock valued at $478,000 after purchasing an additional 775 shares during the last quarter. 96.62% of the stock is currently owned by institutional investors.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.